Tavaborole is an antifungal medication belonging to the oxaborole class, used for the topical treatment of onychomycosis, a common fungal nail infection. By inhibiting fungal protein synthesis, it effectively… Read more





![Chemical structure of 2,9-Difluorodibenzo[c,h][1,6,2,7]dioxadiborecine-5,12(7H,14H)-diol](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2113611-05-3-29-Difluorodibenzoch1627dioxadiborecine-5127H14H-diol.png&w=3840&q=75)






![Chemical structure of 4-Fluorobenzo[c][1,2]oxaborol-1(3H)-ol](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F174671-88-6-4-Fluorobenzoc12oxaborol-13H-ol.png&w=3840&q=75)





Tavaborole is an antifungal medication belonging to the oxaborole class, used for the topical treatment of onychomycosis, a common fungal nail infection. By inhibiting fungal protein synthesis, it effectively halts the growth of susceptible fungi. To support the analytical development and quality assurance of this drug, laboratories rely on high-quality reference standards, which are essential for rigorous impurity profiling and method validation. This collection includes Tavaborole API, its identified process-related impurities, potential degradation products, and dimers. Additionally, stable isotope labelled compounds are available to serve as reliable internal standards in complex analytical procedures, such as mass spectrometry, ensuring accurate quantification and consistent monitoring of impurity levels during pharmaceutical quality control and regulatory testing.